methylprednisolone tablet
zydus lifesciences limited - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - methylprednisolone tablets are indicated in the following conditions: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post-traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic carditis
medrol- methylprednisolone tablet
zoetis inc. - methylprednisolone (unii: x4w7zr7023) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 4 mg - the indications for medrol tablets are the same as those for other anti-inflammatory steroids and comprise the various collagen, dermal, allergic, ocular, otic, and musculoskeletal conditions known to be responsive to the anti-inflammatory corticosteroids. representative of the conditions in which the use of steroid therapy and the benefits to be derived therefrom have had repeated confirmation in the veterinary literature are: (1) dermal conditions, such as non-specific eczema, summer dermatitis, and burns; (2) allergic manifestations, such as acute urticaria, allergic dermatitis, drug and serum reactions, bronchial asthma, and pollen sensitivities; (3) ocular conditions, such as iritis, iridocyclitis, secondary glaucoma, uveitis, and chorioretinitis; (4) otic conditions, such as otitis externa; (5) musculoskeletal conditions, such as myositis, rheumatoid arthritis, osteoarthritis, and bursitis; (6) various chronic or recurrent diseases of unknown etiology such as ulcerative colitis and nephrosis. in acute a
r70 long lasting algaecide
pool resources pty limited - copper (cu) present as cupric amine complex - pool algicide - swimming pool - algae
r70 wipe out superchlorination and shock treatment
waterco limited - chlorine present as calcium hypochlorite hydrated - pool chlorine - swimming pool - algae | bacteria
r70 chlorine stabilised granular pool chlorine
aps watercare a div of asia pacific specialty chemicals - chlorine present as sodium dichloroisocyanurate dihydrat - pool algicide - swimming pool - algae | bacteria
r70 chlorine tabs trichlor tablets
aps watercare a div of asia pacific specialty chemicals - chlorine present as trichloroisocyanuric acid - pool chlorine - saltwater pool | swimming pool | swimming pool - saltwater - algae | bacteria
r70 algi-killer pool water algaecide
aps watercare a div of asia pacific specialty chemicals - poly oxyethylene (dimethyliminio) ethylene (dimethyl.... - algicide - spa | swimming pool | outdoor spa | spa pools - algae
r70 long lasting small trichlor tablets pool water sanitizer
aps watercare a div of asia pacific specialty chemicals - chlorine present as trichloroisocyanuric acid - algicide - swimming pool - algae | bacteria
r70 long lasting bromine sanitizer & algaecide for pools & spas
aps watercare a div of asia pacific specialty chemicals - bromine present as bromo-chloro-dimethylhydantoin | chlorine present as bromo-chloro-dimethylhydantoin - algicide - spa | swimming pool | outdoor spa | spa pools - algae | bacteria | water treatment/sanitiser
r70 black spot algaecide
aps watercare a div of asia pacific specialty chemicals - not entered yet - algicide